Gene-sequencing company Pacific BioSciences of California Inc. on Tuesday announced the launch of a new, more affordable, higher-throughput “long-read” sequencer as well as customer testing of its first “short-read” sequencer aimed at emerging markets such as multi-cancer early detection.